David's self help companies for 2026
David's self help companies for 2026
About this video
Key points:
Sonic Healthcare (ASX:SHL) offers potential turnaround following new leadership and global expansion focus
Endeavour Group (ASX:EDV) could benefit from asset sales, buybacks, and management changes
Australian technology stocks, including Xero (ASX:XRO), look attractive for long-term investors despite sector weakness
WiseTech (ASX:WTC) and TechnologyOne (ASX:TNE) mentioned as experiencing recent share price declines
David Walsh from Sarto Advisory shines a light on underperforming stocks, highlighting three categories: trending stocks performing well, resilient names despite not trending, and those considered “self-help” opportunities for 2026. Walsh draws special attention to Sonic Healthcare (ASX:SHL), noting its transformation into a global pathology leader, with over $10 billion revenue likely in the coming year. Despite declining share prices due to challenges in earnings growth, Walsh finds the company’s new CEO—its first in 32 years—promising, especially following an AGM focus on earnings and return on capital. He sees potential for operational efficiencies in Sonic Healthcare’s labour- and consumable-intensive model to deliver improved results soon.
Endeavour Group (ASX:EDV) also features in Walsh’s “self-help” list. He points to upcoming management changes and business reviews, suggesting opportunities to sell non-core vineyard assets or pursue licensing partnerships as a way to rationalise the business and potentially fund aggressive share buybacks. Walsh notes a cyclical downturn in alcohol consumption but suggests strategic asset sales could unlock shareholder value, although separating the pub and retail businesses may be more difficult due to licensing complexities.
In the technology sector, Walsh highlights Xero (ASX:XRO) and references recent weakness across leaders such as WiseTech (ASX:WTC) and TechnologyOne (ASX:TNE). He sees long-term opportunity in Xero, citing high switching costs and positive aspects of its US expansion strategy through the Amelio acquisition.